The mutation spectrum induced by the widely used antitumor drug cis-diamminedichloroplatinum(II) (cis-DDP) showed that cisDDP{d(ApG)} adducts, although they account for only 25% of the lesions formed, are =5 times more mutagenic than the major GG adduct. We report the construction of vectors bearing a single cisDDP{d(ApG)} lesion and their use in mutagenesis experiments in Escherichia coli. The mutagenic processing of the lesion is found to depend strictly on induction of the SOS system of the bacterial host cells. In SOS-induced cells, mutation frequencies of 1-2% were detected. All these mutations are targeted to the 5' base of the adduct. Single A -+ T transversions are mainly observed (80%), whereas A -* G transitions account for 10% of the total mutations. Tandem base-pair substitutions involving the adenine residue and the thymine residue immediately 5' to the adduct occur at a comparable frequency (10%). No selective loss of the strand bearing the platinum adduct was seen, suggesting that, in vivo, cisDDP{d(ApG)} adducts are not blocking lesions. The high mutation specificity of cisDDP{d(ApG)}-induced mutagenesis is discussed in relation to structural data.
ABSTRACT
The mutation spectrum induced by the widely used antitumor drug cis-diamminedichloroplatinum(II) (cis-DDP) showed that cisDDP{d(ApG)} adducts, although they account for only 25% of the lesions formed, are =5 times more mutagenic than the major GG adduct. We report the construction of vectors bearing a single cisDDP{d(ApG)} lesion and their use in mutagenesis experiments in Escherichia coli. The mutagenic processing of the lesion is found to depend strictly on induction of the SOS system of the bacterial host cells. In SOS-induced cells, mutation frequencies of 1-2% were detected. All these mutations are targeted to the 5' base of the adduct. Single A -+ T transversions are mainly observed (80%), whereas A -* G transitions account for 10% of the total mutations. Tandem base-pair substitutions involving the adenine residue and the thymine residue immediately 5' to the adduct occur at a comparable frequency (10%). No selective loss of the strand bearing the platinum adduct was seen, suggesting that, in vivo, cisDDP{d(ApG)} adducts are not blocking lesions. The high mutation specificity of cisDDP{d(ApG)}-induced mutagenesis is discussed in relation to structural data.
During the past decade, progress in molecular biology allowed the development of strategies for elucidating the molecular mechanisms involved in processing the damages introduced in DNA by physical or chemical agents. A general procedure is to determine the forward mutation spectrum induced by a particular agent on a target DNA sequence (1) . This approach allows definition of the general characteristics of the mutagenic processes, such as their genetic requirements and their specificity. However, these strategies are not sensitive enough to measure the relative contribution of different adducts in repair or mutagenesis events. This problem has been overcome by the use of synthetic oligodeoxyribonucleotides containing defined adducts located at precise sites (for review, see ref.
2). When these adducts are introduced in a replicative vector and transfected into cells, several biological endpoints can be monitored: toxicity (3, 4) , mutation efficiency and specificity (3) (4) (5) (6) , effect of the repair genotype of the host (7), and effect of surrounding sequences (3, 6) . Furthermore, such modified oligonucleotides became useful tools for studying the structure of the DNA helix in the vicinity of the adduct (8-13) and precise biochemistry of repair (14) (15) (16) .
cis-Diamminedichloroplatinum(II) (cisDDP) is a widely used antitumor drug that binds to DNA, its main cellular target, by preferentially forming intrastrand crosslinks between the N7 atoms of adjacent purines (17) (18) (19) . At low modification levels, the main adducts result from the chelation of two adjacent guanines [cisDDP{d(GpG)}], 65% of total lesions), whereas 25% of the adducts arise at 5' d(ApG) sequences. d(GpHpG) adduct (H = A, C, or T) and interstrand crosslinks altogether represent <10% of the total lesions (20) (21) (22) .
We have described the spectrum of mutations induced by cisDDP in Escherichia coli (23) , using a forward mutation assay based on inactivation of the tetracycline resistance gene of pBR322 (1) . We have shown that the minor adduct formed on d(ApG) sequences is at least 5-fold more mutagenic than the major cisDDP{d(GpG)} adduct.
To get more insight into the specificity of the mutagenic processing of these lesions, we conducted mutagenesis experiments by using a probe specifically designed to study the mutagenesis induced by a single cisDDP{d(ApG)} adduct.
MATERIAL AND METHODS Strains, Vectors, and Oligonucleotides. Strain W71/18
[A(lac-pro),rpsL/F'lacIqlacZAM15, proB+A+] was used as host bacteria. Plasmid DNA was prepared and purified on cesium chloride gradients as described (24) . For rapid purification of plasmids we used the minipreparation procedure of Holmes and Quigley (25) . pEMBL8(-) plasmid is a gift from G. Cesarini (EMBL, Heidelberg) (26) . pSM9 plasmid is a derivative of pEMBL8(-): it results from the cloning of the duplex d{(AACTAGTTC)(GAACTAGTT)} in the unique HincIl site located in the polylinker region of pEMBL8(-).
Media and Antibiotics. Bacterial suspensions are grown in Luria broth medium containing ampicillin (50 ,ug/ml) when needed. Transformed cells are plated on medium containing isopropyl,3-D-thiogalactopyranoside (60 ,g/ml), 5-bromo-4-chloro-3-indolyl P-D-galactopyranoside (X-Gal) (50 ,ug/ml), and ampicillin (100 ,g/ml).
Enzymes. Restriction enzymes Cla I, Sal I, and Spe I were purchased from New England Biolabs and HincII was from Promega. P1 nuclease and alkaline phosphatase were from Boehringer Mannheim, DNase I was from Sigma, and snake venom phosphodiesterase and calf spleen phosphodiesterase were from Worthington. All enzymes were used as specified by the suppliers. Sequence analysis was performed using the Sequenase kit of United States Biochemical or T7 polymerase from Amersham.
Bacterial Transformation. Bacteria were made competent for transformation by the CaC12 procedure (27) . Bacteria are UV-irradiated in MgSO4 (0.01 M) at a fluence ranging from 50 to 70 J/m2 to induce the SOS system (6).
Oligonucleotide Synthesis, Modification by cisDDP, and Purification. The 9-mer d(ApApCpTpApGpTpTpC) was synthesized by a phosphotriester method in solution (28) and purified by reverse-phase HPLC. The NH' salt of the Abbreviations: cisDDP, cis-diamminedichloroplatinum(II); X-Gal, 5-bromo-4-chloro-3-indolyl B-D-galactopyranoside.
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The reaction between the diaqua complex and the nonanucleotide (one Pt per nonanucleotide strand) was run at a concentration of -5 x 10-5 M determined by UV absorption (estimated E260, 72,000 cm-1lM-1) in doubly distilled water at pH 5.5-6. The crude reaction mixture was treated with a KCI solution to eliminate any water-platinum species and lyophilized before preparative HPLC. The reverse-phase HPLC analysis and separations were performed on a Nucleosil C8, 5-gum, 300-A semipreparative column (250*4). Eluent A was aqueous CH3CO2NH4 (2 x 10-2 M), pH 6.3, and eluent B was H20/CH3CN, 1:1. (Flow rate, 2 ml/min; gradient, %B = 13% for 2 min and then %B to 23% in 10 min.) HPLC monitoring of the reaction revealed the formation of a main adduct that accounted for 40% of the overall products.
The oligonucleotides were radioactively labeled using T4 polynucleotide kinase, and the phosphorylated forms were purified on 20% polyacrylamide denaturing gel. After overnight elution in 0.3 M sodium acetate buffer and precipitation with ethanol, the oligonucleotides were redissolved in water.
Construction of Vectors Used in Mutagenesis Experiments. The same general strategy, as described elsewhere (30), was followed with few modifications. pEMBL8(-) and pSM9 plasmids were linearized with HincII and Cla I restriction enzymes, respectively. When specified, UV-irradiated linearized pSM9 plasmid DNA was used in construction of the gapped-duplex. UV irradiation at 240 J/m2 was performed in water in a 1-mm quartz cuvette at DNA concentration of 0.1 ,g/ml, yielding an average of five to six UV lesions per plasmid strand (31) . Equal quantities of linearized pEMBL8(-) and pSM9 (UV-irradiated or not) were mixed, heat-denatured, and allowed to renature as described (30) . Purified 9-mer oligonucleotides were mixed with the crude mixture containing gapped-duplex molecules. After hybridization and ligation, the covalently closed circular plasmids were purified on a CsCl gradient. Recovery (underlined) and results in incorporation of an in-frame nonsense amber codon (in boldface) in the early part of the a fragment of the lacZ gene (see Fig. 1 ). When propagated in a suppressor-free strain, this plasmid, pSM9, forms white colonies on X-Galcontaining plates. All base-substitution events that will change the nonsense codon into a sense one will give rise to blue colonies. In other words, this assay detects phenotypically (i.e., color change from white to blue) all possible base-substitution events involving the TAG triplet except the G -* A transition that changes the amber codon into an ochre codon (TAG -* TAA). The d(ApG) dinucleotide contained in the oligonucleotide is the target for cisDDP adduct formation.
Characterization of the cisDDP{d(ApG)} Adduct. Analysis of the main platination adduct by atomic absorption spectroscopy (Perkin-Elmer A560 with HGA-500 graphite furnace) coupled to the UV absorption (with E assumed to be 72,000 cm-l M-1) showed that it was monomeric and contained one platinum atom.
The NMR spectrum of this adduct (0.5 x 10-3 M) was recorded in 99.95% 2H20 at 70TC on a Bruker WM 250 NMR spectrometer. The spectrum of the nonexchangeable protons exhibits two signals at 8.96 and 9.11 ppm (from trimethylsilyl-3-propionic acid d4-2,2,3,3). These downfield-shifted resonances, together with the fast H-2H exchange of the first one, are comparable to those observed for the adenine (H8) and guanine (H8) protons of previously described cisDDP{d(ApG)} chelates (33, 34) .
Enzymatic digestions were used to confirm assignment of the coordinated purines. The (35, 36) . After incubation with snake venom phosphodiesterase at room temperature followed by alkaline phosphatase treatment, measurement of the released nucleosides yielded a 1:2 ratio for dC and dT residues, respectively, showing clearly that platinum is bound to guanine (6) .
Similarly, digestion with calf spleen phosphodiesterase (35, 36) , which hydrolyzes the phosphodiester linkages starting from the 5'-OH end followed by alkaline phosphatase digestion yielded only cytosine and adenine nucleosides in a 1:2 ratio. Even after longer incubation times (72 hr), only a very small amount ofdT could be detected, showing that calf spleen phosphodiesterase cannot hydrolyze the phosphodiester linkage at the 5' side of the cisDDP{d(ApG)} chelate, whereas this phosphodiesterase does so in these conditions with an oligonucleotide containing a cisDDP{d(GpG)} chelate (37) . The NMR and digestion data combined identify the main platination adduct as cis-[Pt(NH3)2{d(ApApCpTpApGpTpTpC)-
Construction of Vector. The strategy shown in Fig. 1 is similar to that described earlier (6, 30) . Four different plasmids were constructed as described in Material and Methods and designated p9, p9Pt, pu,9, and pu,9Pt. Plasmids p9 and p9Pt result from the incorporation of the unmodified or cis-DDP-monomodified nonanucleotide in the gapped-duplex molecule, respectively. In plasmids Puv9 and puv9Pt, the same oligonucleotides were incorporated in gapped-duplex molecules, bearing an average of five to six UV lesions in the strand opposite to the cis-platinum-containing strand. Previous papers have shown that platinum adducts inhibit the activity of different restriction endonucleases (38, 39) . The presence and position of the platinum adduct in the reconstructed plasmids were confirmed by specific inhibition of the Spe I restriction enzyme activity on the cis-DDP-containing plasmids (Fig. 2) .
Mutagenesis Experiments. CAACTBGTTCGAC) (B = G, T, or C), which differ by one base at the eighth nucleotide position. Hybridization analysis of the positive blue clones with these three probes allowed us to determine the exact base change that occurred at the eighth nucleotide. The predicted nature of the mutations was confirmed by sequencing the plasmids extracted from clones chosen on the basis of their hybridization profile. Among 54 mutant plasmids sequenced, all were found to be targeted to the site of the adduct, thus confirming an observation made in other single-adduct mutagenesis studies (3, 6, 40) . More precisely, all mutant plasmids had a base substitution involving the adenine residue of the cisDDP{d(ApG)} adduct, as expected from previous mutation spectrum studies (23) . Also in agreement with previous observations, cis-platinuminduced mutagenesis depends strictly upon induction of the host-cell SOS system (23) . In uninduced cells, mutation frequency with plasmid puv9Pt was estimated as <0.2 X 10-3 (Table 1) . When the cells are SOS induced, mutation frequency rises by >2 orders of magnitude (Table 1) . Average efficiency of conversion of a cisDDP{d(ApG)} adduct into a mutation [mutation cross section (41)] can be estimated from our previously published mutation spectrum (23) at equal to 10-2. The mutation cross section determined in this study with a single cisDDP{d(ApG)} adduct was =1.4-2 x 10-2 (as deduced from Table 1 ), a value agreeing well with the previous estimation. We stress that these mutation cross section values were determined in excisionrepair-proficient strains (ref. 23 , this study) and that a different mutation cross section value can be expected for the same adduct in a repair-deficient strain.
In SOS-induced cells, =80% of the mutants recovered with both constructions p9Pt and pu,9Pt exhibits a single A --T transversion, involving the adenine residue of the cisDDP{d(ApG)} adduct ( The exact position of the platinum adduct in the purified plasmids was assessed by a double-restriction assay. Vectors were digested by both Cla I and Spe I restriction enzymes (1 hr at 37°C) (Left), and the products were analyzed on 1.4% agarose gel without ethidium bromide (Right). Cla I enzyme was chosen so that the 32P-labeled 5' end of the 9-mer remained in the large fragment of the double-restricted plasmid. After migration (2 hr, 70 V), the gel was stained with ethidium bromide, dried, and autoradiographed. The autoradiogram shows the migration profile of plasmids p9 and p9Pt. In the absence of enzymes, unmodified or platinated plasmids migrated as a single 3.9-kilobase (kb) band corresponding to circular form II DNA. Treatment of unmodified plasmids with Spe I/Cla I gave a single radioactive band of 3.3 kb; a second band of 0.6 kb was seen under UV light (far right). Restriction of p9Pt with Spe I/Cla I yielded a single 3.9-kb band of linear DNA (form III). Loss of the Spe I restriction site is attributed to cisDDP{d(ApG)} adduct on the d(ApG) sequence.
Biochemistry: Burnouf et irradiated before transformation at a UV dose of 50-70 J/m2. Some blue colonies contained the starting pEMBL plasmid; these plasmids were apparently carried over during construction and represent background noise in phenotypic selection of mutants. Typical frequency of this background was -5 x 10-3. ND, not determined.
mutants were detected on the basis of a weak hybridization profile with any of the three probes. Among 10 double mutants sequenced, all had an A --T transversion, the second base change being a T -+ C transition (nine cases) or a T --A transversion (one case). The mutational specificity determined in this work is in good agreement with and extends the data derived from the mutation spectrum analysis (23) .
The single-adduct mutagenesis study presented here is characterized by two principal features. (i) Mutations only occur at the 5' base of the cisDDP{d(ApG)} diadduct-i.e., the adenine residue. Recall that the present assay can detect all base changes occurring at the guanine residue except for G -* A transitions. Moreover, if a mutation had occurred on the 3' guanine, it would have been detected by a weak hybridization profile. We note that in the mutational spectrum no mutants involving the 3' base of any potential cisDDP{d(ApG)} adducts were found (23) . (ii) There is a strong specificity for the induction of A --T transversions. Finally, a good correlation exists between the biological data presented here and structural data obtained by others (see below).
The Specific cisDDP Adduct-Induced Mutagenesis Displays No Strand-Loss Phenomenon. Previous work in our laboratory showed that a plasmid, bearing an average of two to three N-acetylaminofluorene adducts in one strand only of a double-stranded molecule, undergoes the specific loss of the adduct-containing strand (42) . It was suggested that, in the course of the replication process, an N-acetylaminofluorene adduct acts as a blocking lesion that functionally dissociates the polymerase III holoenzyme dimer (43) , leading to the loss of the adduct-containing strand. In the course of singleadduct mutagenesis experiments, to avoid the loss of the strand bearing the single adduct, we introduced UV lesions at random within the strand not containing the single adduct of interest (ref. 6 , this work). Unexpectedly, however, we These mutants, in most cases, were TpA -* CpT changes.
found here that the mutation frequency and specificity are identical, whether or not the vector bears UV lesions in the complementary strand (Tables 1 and 2 ), suggesting that unlike N-acetylaminofluorene adducts, the cisDDP{d(ApG)} adduct is not blocking the replication fork and, therefore, not triggering the strand-loss phenomenon. However, this contrasts with in vitro DNA synthesis experiments showing that cisDDP{d(GpG)} and, to a lesser extent, cisDDP{d(ApG)} adducts block E. coli DNA polymerase I and different eukaryotic DNA polymerases (44) (45) (46) . It is obvious that E. coli DNA polymerase I does not accurately reflect the in vivo situation where replication is performed by the holoenzyme DNA polymerase III complex under SOS-induced conditions (47) .
Analysis of the cisDDP{d(ApG)}-Induced Mutations in View of Structural Data. Specificity of mutagenesis induced by a given mutagen is thought to be closely related to the structure of the premutagenic lesion and to the deformation undergone by the modified DNA sequence. Different studies have focused on the determination of the structure of the cisDDP{d(GpG)} lesion. NMR studies (10-13), molecular mechanic calculations (48, 49) , and analysis in solution (12, 50) favored the formation, upon chelation of adjacent guanines, of a kinked or bent structure in DNA. Analysis of NMR data reveals an asymmetric structure for the cisDDP{d(GpG)} adduct: the two guanines are in an anti-anti configuration, and the 5' nucleoside has a (C3'-endo) conformation; meanwhile, the 3' is 70% in a (C2'-endo) conformation (13, 51, 52) . A similar conclusion has also been reached from crystallographic analysis of a cisDDP-modified dinucleotide d(GpG) (19) . Limited data are available concerning the structure of the cisDDP{d(ApG)} lesion. At least at the dinucleotide level, the structure of both d(GpG) and d(ApG) adducts is similar (33, 34) . Chemical probes analysis (50, 53) shows that the local distortion of DNA concerns the 5' side of the d(ApG) adduct, whereas the 3' guanine is still paired. This is confirmed by the NMR analysis of the d(CTCA*G*CCTC)-(GAGGCTGAG) duplex platinated on the bases marked with asterisks (C.G., E. Guittet, J. Igolen, J. Y. Lallemand, and J.C.C., unpublished work). Retardation of migration of a cisDDP{d(ApG)}-bearing oligonucleotide also suggests that this lesion bends DNA (53) . Moreover, this adduct, when formed in the sequence YAG, appears more disruptive than when formed in RAG (50) . In identifying the cisDDP{d(ApG)} adduct by enzymatic digestion, we found that neither P1 nuclease nor calf spleen phosphodiesterase could hydrolyze the phosphodiester bond between thymine and adenine on the 5' side of the chelate. Others have observed the same (21, 22) , although Eastman (22) found that the undigested bond is located on the 3' side of the lesion. We have no explanation for this discrepancy. The resistance to phosphodiesterase processing reflects an altered conformation of the backbone, which, in our case, is located 5' to the adduct. 
